Trials (Cancer Center of Kuopio University Hospital) - Revision history

Francine at 18:23, 14 December 2025

2025-12-14T18:23:32Z

← Older revision		Revision as of 18:23, 14 December 2025
Line 4:		Line 4:
	<span style="display:none">finlandcountry</span>		<span style="display:none">finlandcountry</span>
	Go back to [[Cancer Center of Kuopio University Hospital]] page		Go back to [[Cancer Center of Kuopio University Hospital]] page

			=== Trials: How to participate ===
			'''Contact information:''' [https://pshyvinvointialue.fi/clinical-trial-office Click here to access].


	'''NCTID''': NCT04597125		'''NCTID''': NCT04597125
Line 455:		Line 459:
	<span style="display:none">hasCancerType::D37-D48: Growths of uncertain nature</span>		<span style="display:none">hasCancerType::D37-D48: Growths of uncertain nature</span>
	<span style="display:none">hasCancerType::unknown</span>		<span style="display:none">hasCancerType::unknown</span>
			<span style="display:none">isTrial</span>

Lucas: Update categories.

2025-12-06T12:40:11Z

Update categories.

← Older revision		Revision as of 12:40, 6 December 2025
Line 434:		Line 434:
	<span style="display:none">hasTrialTitle::A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia</span>		<span style="display:none">hasTrialTitle::A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia</span>
	<span style="display:none">hasTrialTitle::A Study to Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in Combination With Standard of Care in Patients With Hematological Malignancies (BEXMAB)</span>		<span style="display:none">hasTrialTitle::A Study to Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in Combination With Standard of Care in Patients With Hematological Malignancies (BEXMAB)</span>
			<span style="display:none">hasCancerType::C00-D48: All neoplasms</span>
			<span style="display:none">hasCancerType::C00-C97: All cancer types</span>
			<span style="display:none">hasCancerType::C00-C14: Mouth/throat cancers</span>
			<span style="display:none">hasCancerType::C15-C26: Digestive system cancers</span>
			<span style="display:none">hasCancerType::C30-C39: Lung/chest cancers</span>
			<span style="display:none">hasCancerType::C40-C41: Bone cancers</span>
			<span style="display:none">hasCancerType::C43-C44: Skin cancers/melanoma</span>
			<span style="display:none">hasCancerType::C45-C49: Soft tissue cancer</span>
			<span style="display:none">hasCancerType::C50: Breast cancer</span>
			<span style="display:none">hasCancerType::C51-C58: Female genitalia cancers</span>
			<span style="display:none">hasCancerType::C60-C63: Male genitalia cancer</span>
			<span style="display:none">hasCancerType::C64-C68: Urinary system cancers</span>
			<span style="display:none">hasCancerType::C69-C72: Eye and brain cancer</span>
			<span style="display:none">hasCancerType::C73-C75: Thyroid and other gland cancers</span>
			<span style="display:none">hasCancerType::C76-C80: Cancers of unknown or unspecified areas</span>
			<span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span>
			<span style="display:none">hasCancerType::C97-C97: Cancers in multiple locations from the start</span>
			<span style="display:none">hasCancerType::D00-D09: Early-stage cancers not yet spread</span>
			<span style="display:none">hasCancerType::D10-D36: Benign tumour</span>
			<span style="display:none">hasCancerType::D37-D48: Growths of uncertain nature</span>
			<span style="display:none">hasCancerType::unknown</span>

Francine at 20:31, 2 December 2025

2025-12-02T20:31:54Z

← Older revision		Revision as of 20:31, 2 December 2025
Line 2:		Line 2:
	<span style="display:none">forproviders</span>		<span style="display:none">forproviders</span>
	<span style="display:none">forresearchers</span>		<span style="display:none">forresearchers</span>
	<span style="display:none">~~finland~~</span>		<span style="display:none">finlandcountry</span>
	Go back to [[Cancer Center of Kuopio University Hospital]] page		Go back to [[Cancer Center of Kuopio University Hospital]] page

Lucas: Update categories.

2025-12-02T13:58:23Z

Update categories.

@@ Line 1: / Line 1: @@
-{{forpatients}}
+<span style="display:none">forpatients</span>
-{{forproviders}}
+<span style="display:none">forproviders</span>
-{{forresearchers}}
+<span style="display:none">forresearchers</span>
-{{finland}}
+<span style="display:none">finland</span>
 Go back to [[Cancer Center of Kuopio University Hospital]] page
@@ Line 395: / Line 395: @@
   '''Recruitment Status''': RECRUITING
   '''Condition''': Acute Myeloid Leukemia

Victor at 00:01, 6 November 2024

2024-11-06T00:01:45Z

← Older revision		Revision as of 00:01, 6 November 2024
Line 2:		Line 2:
	{{forproviders}}		{{forproviders}}
	{{forresearchers}}		{{forresearchers}}
			{{finland}}
	Go back to [[Cancer Center of Kuopio University Hospital]] page		Go back to [[Cancer Center of Kuopio University Hospital]] page

Francine at 15:28, 4 January 2024

2024-01-04T15:28:16Z

Show changes

Francine: Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Cancer Center of Kuopio University Hospital page '''NCTID''': NCT04597125 '''Title''': Investigation of Radium-223 Dichloride (Xofigo), a Treatment That Gives Off Radiation That Helps Kill Cancer Cells, Compared to a Treatment That Inactivates Hormones (New Antihormonal Therapy, NAH) in Patients With Prostate Cancer That Has Spread to the Bone Getting Worse on or After Earlier NAH '''Study Summary''':..."

2023-12-01T21:22:48Z

Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Cancer Center of Kuopio University Hospital page '''NCTID''': NCT04597125 '''Title''': Investigation of Radium-223 Dichloride (Xofigo), a Treatment That Gives Off Radiation That Helps Kill Cancer Cells, Compared to a Treatment That Inactivates Hormones (New Antihormonal Therapy, NAH) in Patients With Prostate Cancer That Has Spread to the Bone Getting Worse on or After Earlier NAH '''Study Summary''':..."

Show changes